|
+175
|
Worlds Worst MDs Competition (2026 Edition)
|
IB
|
3h |
|
+173
|
Who Killed Wall Street
|
IB
|
58s |
|
+163
|
As Lehman people reconvene at UBS, Barclays needs to hire (2023)
|
IB
|
3d |
|
+119
|
Lindsay Clancy - Thoughts from A2
|
IB
|
7h |
|
+94
|
Day at Macquarie
|
IB
|
3d |
|
+79
|
UBS Group AG is coming under renewed US pressure over Credit Suisse’s handling of Nazi-Linked accounts
|
OTH
|
5d |
|
+70
|
The Elite Event Driven Multi-Strat Hedge Funds (Elliott, DK, Farallon)
|
HF
|
8h |
|
+63
|
BofA VP killed in random NYC stabbing
|
OFF
|
5d |
|
+56
|
How bad did I mess up
|
IB
|
2h |
|
|
|
+48
|
Bad at IB = … in PE?
|
PE
|
3d |
|
+46
|
What Bank Will Make Women Instantly Fall In Love With Me?
|
OFF
|
4d |
|
+44
|
Analyst Shows Up in the Prada Sped Slipper — What Are You Doing?
|
FASH
|
5d |
|
+42
|
EB (EVR/CVP/LAZ) vs MBB (Bain/BCG)
|
IB
|
1d |
|
+41
|
I Think My Career Is Over - CRE Job Market Discussion
|
RE
|
21h |
|
+38
|
Misrepresented Houston IB
|
IB
|
4d |
|
+37
|
PE partners keep telling me I’ll “get rich” if I’m patient. Am I being naive?
|
PE
|
8h |
|
+34
|
Most technical groups?
|
IB
|
11h |
|
+33
|
Two MF Associate Offers, Same Comp: Private Credit or Secondaries?
|
PE
|
2d |
|
+31
|
Q&A: US Power Trader (Prop/Spec)
|
TR
|
1d |
|
+29
|
How hard is it actually to execute a roll up?
|
PE
|
4d |
|
+29
|
JPM SMALL CAP or WF/JEF/RBC Coverage group
|
IB
|
3d |
|
+29
|
Is there a market for this type of product?
|
RE
|
23h |
|
+28
|
Comp Negotiation - L/S Equity at a Pod
|
HF
|
2d |
|
+28
|
Should I Leave ~$280K Corp Dev for PE?
|
PE
|
7s |
|
|
|
+28
|
Is there any issue with going straight into SSits/OpVal/DD investing as opposed to Rx IBD first?
|
HF
|
1d |
|
+26
|
Getting the VP Promote at the "Wrong" Firm
|
VC
|
23h |
|
+25
|
Lindsay Clansey
|
OFF
|
3h |
|
+24
|
T(ouse)D Securities
|
IB
|
4d |
|
+24
|
How do you guys manage with such little sleep?
|
IB
|
4d |
|
+24
|
Breaking into Hedge Fund as Rx IB VP
|
HF
|
21h |
|
+24
|
Graduated Jobless from an Ivy - Homelessness?
|
JOB
|
12h |
|
+22
|
Internal pivot w/ title step back??
|
PE
|
12h |
|
+21
|
Sharing my Stock Pitch Report Project with y’all.
|
ER
|
4d |
|
+21
|
Western Investment Bankers Deserve No-Minimum-Wage Nannies, and I Want Mine NOW
|
OFF
|
5h |
|
+21
|
Quick thought on career advice
|
PE
|
4d |
|
+21
|
Anyone Actually Outsourcing Underwriting / Asset Management?
|
RE
|
1m |
|
+21
|
Meritocratic IB groups / banks
|
IB
|
1d |
|
+20
|
13+ Years in Investments — Family Office Portfolio Management, Treasury & Personal Investing
|
AM
|
1d |
|
+20
|
Is IB Drilling PPT Useless?
|
PE
|
5d |
|
+19
|
Dating after being nyc hf
|
HF
|
18h |
|
+18
|
Someone tell me the chance of getting the job
|
AM
|
1d |
|
+18
|
MM to BB as AN2, how to actually perform well once you're in?
|
IB
|
5d |
|
+18
|
Negotiating salary in investment bank/ global markets
|
CR
|
11h |
|
+17
|
evercore isnt opening today
|
OFF
|
23h |
|
+17
|
Mckinsey vs BCG SF
|
CO
|
3h |
|
+17
|
Anyone got a view on Longspur Capital in London?
|
IB
|
4d |
|
+17
|
USC Marshall Thoughts?
|
IB
|
16h |
|
+16
|
Does my Masters help me land an analyst role in REPE?
|
RE
|
23h |
|
+16
|
Wall St. MBA Rankings?
|
BSCH
|
4d |
|
+16
|
EVR & PWP on McGill
|
IB
|
4d |
|
+15
|
Charity
|
IB
|
4d |
|
+15
|
LP-side operations, 10+ years behind the platforms allocators actually use, Q&A
|
AM
|
6d |
|
+15
|
Deleted
|
OFF
|
1d |
|
+15
|
Leaving S&T after 4 months? Am I making a mistake?
|
TR
|
9m |
|
+15
|
Competition / Bar for Entry & Job Market
|
IB
|
22h |
|
+15
|
Feeling a bad pattern forming. I need some help
|
IB
|
13h |
|
+15
|
Wall Street Run Club
|
IB
|
1h |
|
+15
|
This sucks
|
IB
|
1d |
|
+14
|
PE Secondaries Case Studies
|
PE
|
6d |
|
+14
|
Hair Transplant
|
OFF
|
9m |
|
+14
|
How to choose a company to analyse given 0 assumptions?
|
PE
|
1d |
|
+14
|
Impostor Syndrome
|
IB
|
3d |
|
+14
|
Any family office guys on WSO that cut +$10M plus checks?
|
HF
|
2d |
|
+13
|
UK masters into NYC project finance. Is this stupid?
|
IB
|
3h |
|
+13
|
DCM/Lev Fin resume question
|
IB
|
2h |
|
+13
|
2024 graduate navigating graduate eligibility restrictions
|
IB
|
1d |
|
+13
|
From BIG4 Audit to Equity/Credit Research -> how to break in
|
ER
|
5d |
|
+13
|
Incoming Analyst Referral Situation
|
IB
|
1d |
|
+13
|
Biotech VC path from Patent Law
|
VC
|
1d |
|
+13
|
At what salary can you start calling it “fi-NANCE”
|
OFF
|
1d |
|
+13
|
Am I living in la la Land
|
ER
|
11h |
|
+13
|
NYC apartment hunting rant: everyone and their mother and brother are touring
|
OFF
|
4h |
|
+12
|
Real estate debt advisory case study, what should go on a one page lender teaser?
|
RE
|
5d |
|
+12
|
Need MBA advice
|
BSCH
|
5d |
|
+12
|
Worth Applying without a Referral?
|
CO
|
5d |
|
+12
|
Freshman targeting macro pods, need guidance
|
HF
|
5d |
|
+12
|
Contacting a senior who opened a new office in my city?
|
PE
|
1d |
|
+12
|
How to negotiate economics as first hire to an independent sponsor
|
PE
|
4d |
|
+12
|
Interesting Biotech / Biopharma Exits from IB? (not PE)
|
IB
|
2d |
|
+11
|
Sourcing/BD → execution in PE — realistic path or pipe dream
|
PE
|
6d |
|
+11
|
Recruiting Advice | Valuation Associate -> Investment side analyst
|
RE
|
2d |
|
+11
|
Has the IB Analyst to IR Associate pathway dried up?
|
IB
|
2h |
|
+11
|
HELP - stuck trying to building a royalty company model
|
RE
|
3d |
|
+10
|
Turning down major fund for boutique?
|
PE
|
2d |
|
+10
|
Perform Properties role - thoughts?
|
RE
|
2d |
|
+10
|
How is the lifestyle in banking/PE in London?
|
PE
|
8h |
|
+10
|
Trading Forum Idea
|
TR
|
2d |
|
+10
|
Striking Out and Need Help Desperately
|
IB
|
4d |
|
+10
|
The Actual Case for Houston vs NYC
|
IB
|
3d |
|
+10
|
HF Analyst to ECM IB Analyst?
|
HF
|
2h |
|
+10
|
Incoming RX analyst
|
IB
|
1d |
|
+10
|
Why are UK MD Profiles often rather „weak“
|
IB
|
20m |
|
+10
|
need help!!
|
BSCH
|
2d |
|
+9
|
2028 SA recruiting
|
IB
|
5d |
|
+9
|
What Is Blockchain? A Beginner-Friendly Explanation for Finance Professionals Understanding Blockchain Beyond the Cryptocurrency Hype
|
CRYPTO
|
6d |
|
+9
|
IB Technical Prep Resources - Thoughts?
|
IB
|
12h |
|
+9
|
Dane Halim: Why Incremental Returns Matter More Than Headline Growth
|
INV
|
1d |
|
+9
|
How would you categorize this experience?
|
PE
|
2d |
|
+9
|
De Beers blood diamonds: How have responsible sourcing and verification helped shape greater transparency in the modern diamond industry?
|
INV
|
4d |
|
+9
|
H/S/W MBA profile chances
|
BSCH
|
3d |
or Want to Sign up with your social account?